NASDAQ:AMTX

Aemetis (AMTX) Stock Price, News & Analysis

$4.14
+0.09 (+2.22%)
(As of 05/8/2024 ET)
Today's Range
$3.92
$4.22
50-Day Range
$2.89
$6.02
52-Week Range
$1.61
$8.99
Volume
559,894 shs
Average Volume
1.09 million shs
Market Capitalization
$176.74 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.30

Aemetis MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
148.8% Upside
$10.30 Price Target
Short Interest
Bearish
12.63% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.52) to ($0.32) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.99 out of 5 stars

Oils/Energy Sector

219th out of 240 stocks

Industrial Organic Chemicals Industry

17th out of 18 stocks

AMTX stock logo

About Aemetis Stock (NASDAQ:AMTX)

Aemetis, Inc. operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products. In addition, it produces and sells ethanol; and wet distillers grains, distillers corn oil, and condensed distillers solubles to dairies and feedlots as animal feed. Further, the company markets and supplies USP alcohol and hand sanitizer; and produces renewable natural gas, as well as distilled biodiesel from various vegetable oil and animal waste feedstocks. Additionally, it researches and develops conversion technologies using waste feedstocks to produce biofuels and biochemicals. Furthermore, it sells biodiesel primarily to government oil marketing companies. Aemetis, Inc. is headquartered in Cupertino, California.

AMTX Stock Price History

AMTX Stock News Headlines

The 2024 Gold Rush: Unleashing Market Potential
Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.
Piper Sandler Keeps Their Sell Rating on Aemetis (AMTX)
The 2024 Gold Rush: Unleashing Market Potential
Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.
Aemetis Inc.
AMTX Jan 2025 7.500 put
AMTX May 2024 3.500 call
AMTX Apr 2024 3.500 put
AMTX Mar 2024 3.000 put
When Will Aemetis, Inc. (NASDAQ:AMTX) Breakeven?
AMTX Jul 2024 10.000 put
See More Headlines
Receive AMTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aemetis and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/07/2024
Today
5/09/2024
Next Earnings (Estimated)
5/09/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Industrial organic chemicals
Sub-Industry
N/A
Current Symbol
NASDAQ:AMTX
Employees
205
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$10.30
High Stock Price Target
$28.00
Low Stock Price Target
$3.00
Potential Upside/Downside
+148.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Net Income
$-46,420,000.00
Pretax Margin
-53.64%

Debt

Sales & Book Value

Annual Sales
$186.72 million
Book Value
($5.49) per share

Miscellaneous

Free Float
35,673,000
Market Cap
$176.74 million
Optionable
Optionable
Beta
1.16
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

AMTX Stock Analysis - Frequently Asked Questions

Should I buy or sell Aemetis stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Aemetis in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" AMTX shares.
View AMTX analyst ratings
or view top-rated stocks.

What is Aemetis' stock price target for 2024?

4 brokerages have issued twelve-month price objectives for Aemetis' stock. Their AMTX share price targets range from $3.00 to $28.00. On average, they expect the company's stock price to reach $10.30 in the next year. This suggests a possible upside of 148.8% from the stock's current price.
View analysts price targets for AMTX
or view top-rated stocks among Wall Street analysts.

How have AMTX shares performed in 2024?

Aemetis' stock was trading at $5.24 at the start of the year. Since then, AMTX stock has decreased by 21.0% and is now trading at $4.14.
View the best growth stocks for 2024 here
.

Are investors shorting Aemetis?

Aemetis saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 5,320,000 shares, an increase of 14.7% from the March 15th total of 4,640,000 shares. Based on an average trading volume of 1,220,000 shares, the days-to-cover ratio is presently 4.4 days.
View Aemetis' Short Interest
.

When is Aemetis' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our AMTX earnings forecast
.

How were Aemetis' earnings last quarter?

Aemetis, Inc. (NASDAQ:AMTX) announced its earnings results on Thursday, March, 7th. The specialty chemicals company reported ($0.34) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.35) by $0.01. The specialty chemicals company had revenue of $70.76 million for the quarter, compared to analysts' expectations of $80.08 million. During the same quarter last year, the firm earned ($0.63) earnings per share.

What other stocks do shareholders of Aemetis own?
Who are Aemetis' major shareholders?

Aemetis' stock is owned by a variety of institutional and retail investors. Top institutional investors include Simplex Trading LLC (0.00%), Susquehanna Fundamental Investments LLC (0.08%), SG Americas Securities LLC (0.02%), Russell Investments Group Ltd. (0.02%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Andrew B Foster, Andrew B Foster, Francis P Barton, John R Block, John R Block, Naomi Louise Boness, Sanjeev Gupta and Timothy Alan Simon.
View institutional ownership trends
.

How do I buy shares of Aemetis?

Shares of AMTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:AMTX) was last updated on 5/9/2024 by MarketBeat.com Staff

From Our Partners